NEOPLASMS, COLORECTAL
Clinical trials for NEOPLASMS, COLORECTAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, COLORECTAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, COLORECTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial targets genetic weakness in Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing a new oral drug, GSK4418959, for adults with advanced solid tumors that have specific genetic features (called dMMR or MSI-H). The main goals are to find a safe dose, see how the body processes the drug, and check if it can shrink tumors, either …
Matched conditions: NEOPLASMS, COLORECTAL
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for tough cancers: experimental combo targets key mutation
Disease control OngoingThis study is testing new drug combinations for people with advanced solid tumors that have a specific genetic change called KRAS G12C. It focuses on patients with non-small cell lung cancer or colorectal cancer who have already tried standard treatments. The main goals are to fi…
Matched conditions: NEOPLASMS, COLORECTAL
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC